Nafas Journal

1- https://www.who.int/news/item/21-11-2022-who-to-identify-pathogens-that-could-cause-future-outbreaks-and-pandemics.
2- Chua K. B, Goh K. J, Wong K. T, Kamarulzaman A, Tan P. S, Ksiazek T. G, Zaki S. R, Paul G, Lam S. K, Tan C. T. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet (London, England) .1999; 354(9186): 1257–1259. https://doi.org/10.1016/S0140-6736(99)04299-3.
3- https://www.theguardian.com/science/2021/jan/26/pharmaceutical-giants-not-ready-for-next-pandemic-report-warns.
3- Soman Pillai V, Krishna G, Valiya Veettil M. Nipah virus: past outbreaks and future containment. Viruses. 2020; 12(4): 465.
4- Ang B. S, LimT. C, Wang L. Nipah virus infection. Journal of clinical microbiology. 2018; 56(6): e01875-17.
5- Daszak P, Zambrana-Torrelio C, Bogich TL, Fernandez M, Epstein JH, Murray KA, Hamilton H. Interdisciplinary approaches to understanding disease emergence: the past, present, and future drivers of Nipah virus emergence. Proc Natl Acad Sci USA. 110(Supplement_1). 2013; 3681–3688.
6- Field H, Young P, Yob J. M, Mills J, Hall L, Mackenzie J. The natural history of Hendra and Nipah viruses. Microbes and infection. 2001; 3(4): 307-314.
7- Arif SM, Basher A, Quddus MR, Faiz MA. Re-emergence Nipah – a review. Mymensingh Med J. 2012; 21(4): 772–779
8- Ternhag A, Penttinen P. Nipah virus–another product from the Asian virus factory. Lakartidningen. 2005;102(14): 1046–1047.
9- Ciancanelli MJ, Basler CF. Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol. 2006; 80(24):12070–12078. doi: 10.1128/JVI.01743-06.
10- Bossart K. N, BinghamJ, Middleton D. Targeted strategies for Henipavirus therapeutics. The Open Virology Journal. 2007; 1:14-25.
Bossart KN, McEachern JA, Hickey AC, Choudhry V, Dimitrov DS, Eaton BT, Wang LF. Neutralization assays for differential henipa virus serology using BioPlex protein array systems. J Virol Meth. 2007; 142(1–2):29–40.
11- Sulkin S. E Allen R. Virus infections in bats. 1974.
12- Li W, Shi Z, Yu M, Ren W, Smith C, Epstein J. H, Wang H, Crameri G, Hu Z, Zhang H, Zhang J, McEachern J, Field H, Daszak P, Eaton B. T, Zhang S, Wang L. F. Bats are natural reservoirs of SARS-like coronaviruses. Science (New York, N.Y.). 2005; 310(5748): 676–679.
13- Epstein J. H, Field H. E, Luby S, Pulliam J. R, & Daszak P. Nipah virus: impact, origins, and causes of emergence. Current infectious disease reports. 2006; 8(1): 59-65.
14- Pavlovich S. S, Lovett S. P, Koroleva G, Guito J. C, Arnold C. E, Nagle E. R, Kulcsar K, Lee A, Thibaud-Nissen F, Hume A. J, Mühlberger E, Uebelhoer L. S, Towner J. S, Rabadan R, Sanchez-Lockhart M, Kepler T. B, Palacios G. The Egyptian Rousette Genome Reveals Unexpected Features of Bat Antiviral Immunity. Cell. 2018; 173(5):1098–1110.e18.
15- Chaitanya K. R, Anusha V. R. S. Recapitulation of Nipah Virus Disease: Multiple strategies for future therapeutics. Research Journal of Pharmacy and Technology. 2022; 15(9): 4048-4054.
16- Goh K. J, Tan C. T, Chew N. K, Tan P. S. K, Kamarulzaman A, Sarji S. A, Wong K. T, Abdullah B.J. J, Chua K. B, Lam S. K. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. New England Journal of Medicine. 2000; 342(17): 1229-1235.
17- Marty C. A. M, Conran C. R. M, Kortepeter L. M. G. Recent challenges in infectious diseases: biological pathogens as weapons and emerging endemic threats. Clinics in Laboratory Medicine. 2001; 21(3): 411-420.
18- Chua K. B, Koh C. L, Hooi P. S, Wee K. F, Khong J. H, Chua B. H, Chan Y. P, Lim M. E, Lam S. K. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes and infection. 2002; 4(2): 145–151. https://doi.org/10.1016/s1286-4579(01)01522-2
20- Homaira N, Rahman M, Hossain M. J, Epstein J. H, Sultana R, Khan M. S, Podder G, Nahar K, Ahmed B, Gurley E. S, Daszak P, Lipkin W. I, Rollin P. E, Comer J. A, Ksiazek T. G, Luby S. P. Nipah virus outbreak with person-to-person transmission in a district of Bangladesh, 2007. Epidemiology and infection. 2010; 138(11): 1630–1636. https://doi.org/10.1017/S0950268810000695
21- Escaffre O, Hill T, Ikegami T, Juelich TL, Smith JK, Zhang L, Perez DE, Atkins C, Park A, Lawrence WS, et al. Experimental infection of Syrian hamsters with aerosolized Nipah virus. J Infect Dis. 2018; 218(10):1602–1610.
22- Luby S.P, Gurley E.S. Epidemiology of henipavirus disease in humans. Curr. Top. Microbiol. Immunol. 2012;359: 25–40.
23- Gurley E. S, Montgomery J. M, Hossain M. J, Bell M, Azad A. K, Islam M. R, Molla M. A, Carroll D. S, Ksiazek T. G, Rota P. A, Lowe L, Comer J. A, Rollin P, Czub M, Grolla A, Feldmann H, Luby S. P, Woodward J. L, Breiman R. F. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerging infectious diseases. 2007; 13(7): 1031–1037.
24- Parashar U. D, Sunn L. M, Ong F, Mounts A. W, Arif M. T, Ksiazek, T. G, Kamaluddin M.A, Mustaf,A.N, Kaur H, Ding L. M, Othman G, Radzi H. M, Kitsutani P. T, Stockton P. C, Arokiasamy J, Jr H. E. G. Anderson L. J. Case-control study of risk factors for human infection with a new 39-zoonotic paramyxovirus, Nipah virus, during a 1998–1999 outbreak of severe encephalitis in Malaysia. The Journal of infectious diseases. 2000; 181(5): 1755-1759.
25- Kitsutani P, Ohta M. Nipah virus infections. Nihon rinsho. Japanese journal of clinical medicine. 2005; 63(12):2143-2153.
26- Tiong V, Shu M. H, Wong W. F, AbuBakar S, Chang L. Y. Nipah virus infection of immature dendritic cells increases its transendothelial migration across human brain microvascular endothelial cells. Frontiers in microbiology. 2018; 9: 2747.
27- Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT, Broder CC. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad SciUSA. 2005; 102:10652–10657. https://doi.org/10 .1073/pnas.0504887102.
28- Wang L.-F, Mackenzie J.S, Broder C.C. Henipaviruses. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology. Lippincott Williams & Wilkins, Philadelphia. 2013; 1070–1085.
29- Wong K. T, Shieh W. J, Kumar S, Norain K, Abdullah W, Guarner J, Goldsmith C. S, Chua K. B, Lam S. K, Tan C. T, Goh K. J, Chong H. T, Jusoh R, Rollin P. E, Ksiazek T. G, Zaki S. R. Nipah Virus Pathology Working Group. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. The American journal of pathology. 2002; 161(6):2153–2167.
30- Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, Lee B. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature. 2005; 436(7049):401–405.
31- Sauerhering L, Zickler M, Elvert M, Behner L, Matrosovich T, Erbar S, Matrosovich M, Maisner A. Species-specific and individual differences in Nipah virus replication in porcine and human airway epithelial cells. J Gen Virol. 2016; 97(7):1511–1519.
32- Hossain M. J, Gurley E. S, Montgomery J. M, Bell M, Carroll D. S, Hsu V. P, Formenty P, Croisier A, Bertherat E, Faiz M. A, Azad A. K, Islam R, Molla M. A, Ksiazek T. G, Rota P. A, Comer J. A, Rollin P. E, Luby S. P, Breiman R. F. Clinical presentation of nipah virus infection in Bangladesh. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2008; 46(7): 977–984.
33- Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, Niezgoda M, Rupprecht C, Bresee J, Breiman RF. Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis. 2004; 10:2082–2087. https://doi .org/10.3201/eid1012.040701.
34- Ng B. Y, Lim C. T, Yeoh A, & Lee W. L. Neuropsychiatric sequelae of Nipah virus encephalitis. The Journal of neuropsychiatry and clinical neurosciences. 2004; 16(4): 500-504.
35- Sejvar JJ, Hossain J, Saha SK, Gurley ES, Banu S, Hamadani JD, Faiz MA, Siddiqui FM, Mohammad QD, Mollah AH, et al. Long-term neurological and functional outcome in Nipah virus infection. Ann Neurol. 2007; 62(3): 235–242.
36- Chaitanya K. R, Anusha V. R. S. Recapitulation of Nipah Virus Disease: Multiple strategies for future therapeutics. Research Journal of Pharmacy and Technology. 2022; 15(9): 4048-4054.
37- Han H. J, Yu H, Yu X. J. Evidence for zoonotic origins of Middle East respiratory syndrome coronavirus. The Journal of general virology. 2016; 97(2): 274.
38- Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, Pallister J, Geisbert TW, Bossart KN, Wang L-F. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res. 2013; 100(1): 8–13. doi: 10.1016/j.antiviral.2013.06.012
39- Abdullah S, Chang L. Y, Rahmat K, Goh K. J, Tan C. T. Late-onset Nipah virus encephalitis 11 years after the initial outbreak: A case report. Neurology Asia. 2012; 17(1).
40- Lim CC, Lee KE, Lee WL, Tambyah PA, Lee CC, Sitoh YY, Auchus AP, Lin BK, Hui F. Nipah virus encephalitis: serial MR study of an emerging disease. Radiology. 2002; 222:219 –226. https://doi.org/10.1148/ radiol.2221010499.
41- Looi L. M, Chua K. B. Lessons from the Nipah virus outbreak in Malaysia. Malaysian Journal of Pathology. 2007; 29(2): 63-67.
42- Wong K.T, Robertson T, Ong B.B, Chong J.W, Yaiw K.C, Wang L.F, Ansford A.J, Tannenberg A. Human Hendra virus infection causes acute and relapsing encephalitis. Neuropathol. Appl. Neurobiol. 2009; 35: 296–305.
43- Chong H. T, Kamarulzaman A, Tan C. T, Goh K. J, Thayaparan T, Kunjapan S. R, Chew N. K, Chua K. B, Lam S. K. Treatment of acute Nipah encephalitis with ribavirin. Annals of neurology. 2001; 49(6): 810–813.
44- Shariff, M. Nipah virus infection: A review. Epidemiology & Infection. 2019; 147.
45- Guillaume V, Lefeuvre A, Faure C, Marianneau P, Buckland R, Lam S. K, Wild T. F, Deubel V. Specific detection of Nipah virus using real-time RT-PCR (TaqMan). Journal of virological methods. 2004; 120(2): 229-237.
46- Singh R. K, Dhama K, Chakraborty S, Tiwari R, Natesan S, Khandia R, Munjal A, Vora K. S, Latheef S. K, Karthik K., Malik Y. S, Singh R, Chaicumpa W, Mourya D. T. Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies–a comprehensive review. Veterinary Quarterly. 2019; 39(1): 26-55.
47- Pallister J, Middleton D, Crameri G, Yamada M, Klein R, Hancock T. J, Foord A, Shiell B, Michalski W, Broder C. C, Wang L. F. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets. Journal of virology. 2009; 83(22): 11979–11982.
48- Chattu V. K, Kumar R, Kumary S, Kajal F, David J. K. Nipah virus epidemic in southern India and emphasizing "One Health" approach to ensure global health security. Journal of family medicine and primary care. 2018; 7(2): 275–283.
49- Ambat A. S, Zubair S. M, Prasad N, Pundir P, Rajwar E, Patil D. S, Mangad P. Nipah virus: A review on epidemiological characteristics and outbreaks to inform public health decision making. Journal of infection and public health. 2019; 12(5): 634-639.
50- Sazzad H. M, Hossain M. J, Gurley E. S, Ameen K. M, Parveen S, Islam M. S, Faruque L. I, Podder G, Banu S. S, Lo M. K, Rollin P. E, Rota P. A, Daszak P, Rahman M, Luby S. P. Nipah virus infection outbreak with nosocomial and corpse-to-human transmission, Bangladesh. Emerging infectious diseases. 2013; 19(2): 210–217.
51- Islam M. S, Luby S. P, Gurley E. S. Developing Culturally Appropriate Interventions to Prevent Person-to-Person Transmission of Nipah Virus in Bangladesh: Cultural Epidemiology in Action. In When Culture Impacts Health: Global Lessons for Effective Health Research. 2013; 329-337.